NEXGEL (NXGL) Competitors $3.32 -0.28 (-7.78%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$3.34 +0.02 (+0.45%) As of 02/21/2025 07:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends NXGL vs. MLSS, SRTS, ICAD, HYPR, LUCD, MGRM, NTRB, NSPR, GUTS, and ICCMShould you be buying NEXGEL stock or one of its competitors? The main competitors of NEXGEL include Milestone Scientific (MLSS), Sensus Healthcare (SRTS), iCAD (ICAD), Hyperfine (HYPR), Lucid Diagnostics (LUCD), Monogram Orthopaedics (MGRM), Nutriband (NTRB), InspireMD (NSPR), Fractyl Health (GUTS), and IceCure Medical (ICCM). These companies are all part of the "medical equipment" industry. NEXGEL vs. Milestone Scientific Sensus Healthcare iCAD Hyperfine Lucid Diagnostics Monogram Orthopaedics Nutriband InspireMD Fractyl Health IceCure Medical NEXGEL (NASDAQ:NXGL) and Milestone Scientific (NYSE:MLSS) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, risk, dividends, valuation, media sentiment, analyst recommendations, earnings, institutional ownership and community ranking. Do insiders and institutionals hold more shares of NXGL or MLSS? 2.2% of NEXGEL shares are held by institutional investors. Comparatively, 5.8% of Milestone Scientific shares are held by institutional investors. 24.9% of NEXGEL shares are held by company insiders. Comparatively, 24.8% of Milestone Scientific shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Which has stronger earnings & valuation, NXGL or MLSS? NEXGEL has higher earnings, but lower revenue than Milestone Scientific. Milestone Scientific is trading at a lower price-to-earnings ratio than NEXGEL, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNEXGEL$4.09M5.51-$3.16M-$0.58-5.72Milestone Scientific$9.83M8.24-$6.93M-$0.07-14.86 Do analysts prefer NXGL or MLSS? Milestone Scientific has a consensus target price of $1.25, suggesting a potential upside of 20.19%. Given Milestone Scientific's stronger consensus rating and higher probable upside, analysts clearly believe Milestone Scientific is more favorable than NEXGEL.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NEXGEL 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Milestone Scientific 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility & risk, NXGL or MLSS? NEXGEL has a beta of 0.57, suggesting that its stock price is 43% less volatile than the S&P 500. Comparatively, Milestone Scientific has a beta of 1.14, suggesting that its stock price is 14% more volatile than the S&P 500. Does the media prefer NXGL or MLSS? In the previous week, Milestone Scientific had 1 more articles in the media than NEXGEL. MarketBeat recorded 1 mentions for Milestone Scientific and 0 mentions for NEXGEL. NEXGEL's average media sentiment score of 0.00 equaled Milestone Scientific'saverage media sentiment score. Company Overall Sentiment NEXGEL Neutral Milestone Scientific Neutral Is NXGL or MLSS more profitable? Milestone Scientific has a net margin of -52.01% compared to NEXGEL's net margin of -52.60%. Milestone Scientific's return on equity of -60.26% beat NEXGEL's return on equity.Company Net Margins Return on Equity Return on Assets NEXGEL-52.60% -71.19% -34.79% Milestone Scientific -52.01%-60.26%-40.23% Does the MarketBeat Community favor NXGL or MLSS? Milestone Scientific received 1 more outperform votes than NEXGEL when rated by MarketBeat users. However, 50.00% of users gave NEXGEL an outperform vote while only 2.41% of users gave Milestone Scientific an outperform vote. CompanyUnderperformOutperformNEXGELOutperform Votes150.00% Underperform Votes150.00% Milestone ScientificOutperform Votes22.41%Underperform Votes8197.59% SummaryMilestone Scientific beats NEXGEL on 12 of the 17 factors compared between the two stocks. Get NEXGEL News Delivered to You Automatically Sign up to receive the latest news and ratings for NXGL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NXGL vs. The Competition Export to ExcelMetricNEXGELSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$22.54M$4.59B$5.78B$8.98BDividend YieldN/A39.91%4.78%3.85%P/E Ratio-5.7231.4526.4618.82Price / Sales5.5150.79457.6880.73Price / CashN/A51.2344.0437.47Price / Book3.696.577.634.64Net Income-$3.16M$90.13M$3.18B$245.69M7 Day Performance-5.95%-2.45%-1.82%-2.63%1 Month Performance-1.48%-2.38%0.22%-2.37%1 Year Performance68.53%14.92%17.49%13.65% NEXGEL Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NXGLNEXGELN/A$3.32-7.8%N/A+68.5%$24.45M$6.73M-5.7210Gap DownMLSSMilestone Scientific0.8096 of 5 stars$1.21+0.8%$1.25+3.3%+57.3%$94.25M$9.83M-17.2830News CoverageSRTSSensus Healthcare1.9855 of 5 stars$5.51+0.2%$14.67+166.2%+15.2%$90.31M$41.81M13.7840ICADiCAD0.5813 of 5 stars$3.32-8.0%N/A+92.9%$88.11M$17.32M-25.54140Analyst UpgradeNews CoverageGap UpHYPRHyperfine2.5149 of 5 stars$1.20flat$1.60+33.3%+1.0%$87.54M$13.26M-2.11190Negative NewsLUCDLucid Diagnostics3.1763 of 5 stars$1.46+7.4%$3.63+148.3%+13.2%$86.64M$4.19M-1.2870News CoverageGap UpHigh Trading VolumeMGRMMonogram Orthopaedics3.7979 of 5 stars$2.48-7.8%$4.00+61.3%-24.9%$85.09M$370,000.00-5.2828News CoverageNTRBNutriband2.5668 of 5 stars$7.12-5.9%$13.00+82.6%+205.7%$79.10M$2.09M-10.0310NSPRInspireMD2.414 of 5 stars$2.94+2.8%$4.75+61.6%+22.5%$76.68M$6.20M-3.9250Analyst ForecastGUTSFractyl Health2.1905 of 5 stars$1.58-4.8%$18.00+1,039.2%-82.7%$76.00M$120,000.00-0.13102Gap UpICCMIceCure Medical3.3217 of 5 stars$1.36-0.7%$2.70+98.5%+9.3%$75.48M$3.67M-4.6960Gap Up Related Companies and Tools Related Companies MLSS Alternatives SRTS Alternatives ICAD Alternatives HYPR Alternatives LUCD Alternatives MGRM Alternatives NTRB Alternatives NSPR Alternatives GUTS Alternatives ICCM Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NXGL) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NEXGEL, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NEXGEL With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NXGL Stock Alerts